Cargando…

Pretreatment serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α levels predict the progression of colorectal cancer

The correlations of pretreatment serum concentrations of proinflammatory cytokines such as interleukin (IL)‐1β, IL‐6, and tumor necrosis factor‐α (TNFα) with the clinicopathologic features and progression of colorectal cancer (CRC) were investigated. The pretreatment serum levels of IL‐1β, IL‐6, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Pei‐Hung, Pan, Yi‐Ping, Fan, Chung‐Wei, Tseng, Wen‐Ko, Huang, Jen‐Seng, Wu, Tsung‐Han, Chou, Wen‐Chi, Wang, Cheng‐Hsu, Yeh, Kun‐Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799955/ https://www.ncbi.nlm.nih.gov/pubmed/26799163 http://dx.doi.org/10.1002/cam4.602

Ejemplares similares

Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer
por: Ling, Hang Huong, et al.
Publicado: (2019)

Pretreatment serum CRP and response to interleukin 2.
por: Blay, J. Y., et al.
Publicado: (1994)

Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
por: Yoshida, N, et al.
Publicado: (2002)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019)

The predictive prognostic values of serum interleukin-2, interleukin-6, interleukin-8, tumor necrosis factor-α, and procalcitonin in surgical intensive care unit patients
por: Yan, Yamin, et al.
Publicado: (2021)

Changes in Interleukin-1β, Tumor Necrosis Factor-α, and Interleukin-10 Cytokines in Older People with Periodontitis
por: Sumbayak, Ines Augustina, et al.
Publicado: (2023)

Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer
por: Zhang, Xujun, et al.
Publicado: (2021)

Serum levels of tumor necrosis factor-α, interleukin-15 and interleukin-10 in patients with pre-eclampsia in comparison with normotensive pregnant women
por: Kalantar, Fathollah, et al.
Publicado: (2013)

Serum Levels of Tumor Necrosis Factor-α and Interleukins in Children with Congenital Heart Disease
por: Noori, Noor Mohammand, et al.
Publicado: (2017)

Pretreatment serum markers and lymphocyte response to interleukin-2 therapy
por: Fumagalli, L, et al.
Publicado: (1999)

Sequential cetuximab/bevacizumab therapy is associated with improved outcomes in patients with wild‐type KRAS exon 2 metastatic colorectal cancer
por: Hsu, Hung‐Chih, et al.
Publicado: (2019)

Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy
por: Huang, Pei‐Wei, et al.
Publicado: (2019)

Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
por: Kamil, Zainab A., et al.
Publicado: (2023)

Serum tumor necrosis factor‐α, interleukin‐1β, interleukin‐6, and interleukin‐17 relate to anxiety and depression risks to some extent in non‐small cell lung cancer survivor
por: Liu, Meifang, et al.
Publicado: (2021)

Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial–Mesenchymal Transition
por: Huang, Yu-Han, et al.
Publicado: (2023)

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)

Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
por: Chang, Chun-Chun, et al.
Publicado: (2020)

Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
por: Zheng, Yue, et al.
Publicado: (2013)

Circulating interleukin-8 and tumor necrosis factor-α are associated with hot flashes in healthy postmenopausal women
por: Huang, Wan-Yu, et al.
Publicado: (2017)

The Significant Impacts of Interleukin-8 Genotypes on the Risk of Colorectal Cancer in Taiwan
por: Tsai, Chia-Wen, et al.
Publicado: (2023)

Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
por: Ji, Hong, et al.
Publicado: (2002)

Tumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol Shuttle
por: Escher, Geneviève, et al.
Publicado: (1997)

Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells
por: Tanabe, Kumiko, et al.
Publicado: (2010)

Salivary levels of interleukin-6 and tumor necrosis factor-α in patients undergoing hemodialysis
por: Khozeymeh, Faezeh, et al.
Publicado: (2016)

Expression of Tumor Necrosis Factor‐α and Interleukin‐6 in Oral Squamous Cell Carcinoma
por: Nakano, Yasuko, et al.
Publicado: (1999)

Interleukin-6 and tumor necrosis factor-α levels in tear film of Keratoconus patients
por: Peyman, Alireza, et al.
Publicado: (2021)

Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan
por: Lai, Hsiang‐Lan, et al.
Publicado: (2019)

Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic cancer
por: Lee, Shu‐Hui, et al.
Publicado: (2019)

Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma
por: Skrinjar, Ivana, et al.
Publicado: (2015)

Interleukin‐25: New perspective and state‐of‐the‐art in cancer prognosis and treatment approaches
por: Gowhari Shabgah, Arezoo, et al.
Publicado: (2021)

Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer
por: Brailo, Vlaho, et al.
Publicado: (2012)

Circulating levels of C-reactive protein, interleukin-6 and tumor necrosis factor-α and risk of colorectal adenomas: a meta-analysis
por: Zhang, Xiaoqian, et al.
Publicado: (2016)

Serum Profiles of C-Reactive Protein, Interleukin-8, and Tumor Necrosis Factor-α in Patients with Acute Pancreatitis
por: Digalakis, Michael K., et al.
Publicado: (2009)

Interleukin-6 Mediates Angiotensinogen Gene Expression during Liver Regeneration
por: Lai, Hong-Shiee, et al.
Publicado: (2013)

Interleukin-10 and Tumor Necrosis Factor-α Polymorphisms in Vascular Access Failure in Patients on Hemodialysis: Preliminary Data in Korea
por: Sung, Su Ah, et al.
Publicado: (2008)

Mechanisms of tumor necrosis factor-α and interleukin-6 induction during human liver transplantation
por: Hamilton, Gerhard, et al.
Publicado: (1993)

Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production
por: Brown, Michael D, et al.
Publicado: (2011)

Necrosis-Induced Sterile Inflammation Mediated by Interleukin-1α in Retinal Pigment Epithelial Cells
por: Liu, Yang, et al.
Publicado: (2015)

Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms
por: JAMMAL, MILLENA PRATA, et al.
Publicado: (2015)

Tumor Necrosis Factor‐α and Interleukin‐6 Concentrations in Cerebrospinal Fluid of Dogs After Seizures
por: Merbl, Y., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b35shbibidsv3jekc72tfn398f